In the Media

Using nanotechnology and CRISPR, Prof. Daniel Anderson has turned off a cholesterol-related gene in mouse liver cells, reports Julie Steenhuysen for Reuters.  This new development “could lead to new ways to correct genes that cause high cholesterol and other liver diseases,” Steenhuysen writes.